• Like
Senology.org Newsletter - November 3, 2011
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Senology.org Newsletter - November 3, 2011

  • 375 views
Published

Latest Advances in Clinical Senology and Oncology

Latest Advances in Clinical Senology and Oncology

Published in Health & Medicine , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
375
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Senology Newsletter Page 1 of 4 Senology.org - Newsletter International Senologic and Oncologic  Scientific Community  "Connecting specialists worldwide" Editor-in-Chief: Gian Paolo Andreoletti, MD Subscribe Unsubscribe Contact Back Issues Connecting Specialists Worldwide Join us on Facebook®, Twitter®, YouTube®, LinkedIn®, SlideShare®, Flickr® and Doctorsbook® and share informations, opinions and suggestions. Check out Senology.org Newspaperand follow our RSS feeds for real-time updates Literature Selection Hubbard RA et al.: "Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study", Ann Intern Med. 2011 Oct 18;155(8):481-92 Takeshita T et al.: "Clinical Implications of Occult Metastases and Isolated Tumor Cells in Sentinel and Non-Sentinel Lymph Nodes in Early Breast Cancer Patients: Serial Step Section Analysis with Long- Term Follow-Up", Ann Surg Oncol. 2011 Oct 12. [Epub ahead of print] Han Y et al.: "Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer", Breast Cancer Res Treat. 2011 Oct 5. [Epub ahead of print] Arun B et al.: "Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience", J Clin Oncol. 2011 Oct 1;29(28):3739-46 Mohammadianpanah M et al.: "The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial", Breast Cancer Res Treat. 2011 Oct 16. [Epub ahead of print] Stearns V et al.: "Preclinical and clinical evaluation of intraductally administered agents in early breast cancer", Sci Transl Med. 2011 Oct 26;3(106):106ra108 Regan MM et al.: "Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up", Lancet Oncol. 2011 Oct 20. [Epub ahead of print] Slamon D et al.: "Adjuvant trastuzumab in HER2-positive breast cancer", N Engl J Med. 2011 Oct 6;365 (14):1273-83 Brufsky AM et al.: "Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole", Cancer. 2011 Oct 10 [Epub ahead of print]http://www.senology.org/newsletter/Newsl_Nov2011.htm 03/11/2011
  • 2. Senology Newsletter Page 2 of 4 Adkins FC et al.: "Triple-negative breast cancer is not a contraindication for breast conservation", Ann Surg Oncol. 2011 Oct;18(11):3164-73 Early Breast Cancer Trialists Collaborative Group (EBCTCG): "Effect of radiotherapy after breast- conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials", Lancet. 2011 Oct 19. [Epub ahead of print] Miao H et al.: "Incidence and Outcome of Male Breast Cancer: An International Population-Based Study", J Clin Oncol. 2011 Oct 3. [Epub ahead of print] Comment "Patients with small, node-negative HER2-positive breast carcinoma may benefit from trastuzumab therapy" - Ana Kiess, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA ""Our study shows that women with small, node-negative HER2-positive breast cancer may benefit from trastuzumab therapy. These women actually have a significant risk of local recurrence in the breast after breast conservation therapy (~10%), but trastuzumab may reduce their risk to about 1%" (Comment on: Kiess AP et al.: "Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer", Cancer. 2011 Sep 1. doi: 10.1002/cncr.26484. [Epub ahead of print]) Discussion Welch HG et al.: "Likelihood That a Woman With Screen-Detected Breast Cancer Has Had Her "Life Saved" by That Screening", Arch Intern Med. Published online October 24, 2011, doi:10.1001/archinternmed.2011.476 - What do you think about the conclusions of this study? Share your opinion on LinkedIn® Healthcare Companies News Oncotype DX Newsletter - Genomic Health Calendar of Events 1st Advanced Breast Cancer International Consensus Conference, November 3-5, 2011, Lisbon, Portugal IX Madrid Breast Cancer Conference, November 16 - 17, 2011, Madrid, Spain AORTIC (African Organisation for Research and Training in Cancer) - 8th International Conference, November 28 - December 2, 2011, Cairo, Egypt The 2011 CTRC-AACR San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX The World Cancer Immunotherapy Conference, January 25-26, 2012, San Diego, CA Fragments of History William S Halsted (New York, 1852-1922), "The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894, Ann Surg. 1894 November; 20(5): 497–555: “Now we can state positively that cancer of the breast is a curable disease if operated upon properly and in time. I cannot emphasize too strongly the fact that internal metastases occur very early in cancer of the breast, and this is an additional reason for not losing a day in discussing the propriety of an operation" Literature Selection Gillgren P et al.: "2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial", Lancet. 2011 Oct 21. [Epub ahead of print] Chaturvedi AK et al.: "Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States", J Clin Oncol. 2011 Oct 3. [Epub ahead of print]http://www.senology.org/newsletter/Newsl_Nov2011.htm 03/11/2011
  • 3. Senology Newsletter Page 3 of 4 Palefsky JM et al.: "HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia", N Engl J Med. 2011 Oct 27;365(17):1576-1585 Hvid-Jensen F et al.: "Incidence of Adenocarcinoma among Patients with Barretts Esophagus", N Engl J Med. 2011 Oct 13;365(15):1375-83 Herbrik M et al.: "Diagnostic Accuracy of Virtual 18F-FDG PET/CT Bronchoscopy for the Detection of Lymph Node Metastases in Non-Small Cell Lung Cancer Patients", J Nucl Med. 2011 Oct;52(10):1520-5 Oken MM et al.: "Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial", JAMA. 2011 Oct 26. [Epub ahead of print] Quoix E et al.: "Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non- small-cell lung cancer: a controlled phase 2B trial", Lancet Oncol. 2011 Oct 21. [Epub ahead of print] Ruge M et al.: "Stereotactic Brachytherapy With Iodine-125 Seeds for the Treatment of Inoperable Low-Grade Gliomas in Children: Long-Term Outcome", J Clin Oncol. 2011 Oct 3. [Epub ahead of print] Yang D et al.: "Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer", JAMA. 2011 Oct 12;306(14):1557-65 Klein EA et al.: "Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)", JAMA. 2011 Oct 12;306(14):1549-56 Miyatake H et al.: "Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma", Dig Dis Sci. 2011 Oct 12. [Epub ahead of print] Garcia-Donas J et al.: "Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study", Lancet Oncol. 2011 Oct 17. [Epub ahead of print] Discussion "Screening for Prostate Cancer - A Review of the Evidence for the U.S. Preventive Services Task Force" - "Prostate cancer screening guidelines called into question", Dana-Farber Cancer Institute - Share your opinion on LinkedIn® Literature Selection Vesco KK et al.: "Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force", Ann Intern Med. 2011 Oct 17. [Epub ahead of print] Whitlock EP et al.: "Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the U.S. Preventive Services Task Force", Ann Intern Med. 2011 Oct 17. [Epub ahead of print] Senology.org collaborates with TalkAboutHealth.com - "Breast cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation Stay informed.... Recent Advances in Clinical Medicine OConnor P et al.: "Randomized trial of oral teriflunomide for relapsing multiple sclerosis", N Engl J Med. 2011 Oct 6;365(14):1293-303http://www.senology.org/newsletter/Newsl_Nov2011.htm 03/11/2011
  • 4. Senology Newsletter Page 4 of 4 Unsubscribe       www.senology.orghttp://www.senology.org/newsletter/Newsl_Nov2011.htm 03/11/2011